What is NDC 11673-033?

11673-033 is the product NDC for Dextromethorphan Polistirex, Dextromethorphan 30 mg/5mL suspension, extended release, listed with the FDA by Target Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.

Target Corporation, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dextromethorphan Polistirex?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dextromethorphan Polistirex NDC 11673-033

NDC codes

FDA NDC Directory

Product NDC (as listed)11673-033Labeler and product segments. Claims need a package NDC.

Product NDC at billing width11673-0033Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
11673-033-05	1167300330511673003305	1 BOTTLE in 1 CARTON (11673-033-05) / 148 mL in 1 BOTTLEMarketed from Oct 7, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextromethorphan Polistirex
Generic name (nonproprietary): dextromethorphan polistirex
Active ingredients: Dextromethorphan — 30 mg/5mL
Dosage form: Suspension, Extended release
Route: Oral
Labeler: Target CorporationNDC labeler code 11673
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218417
Marketing start: Oct 7, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Sigma-1 Receptor Agonists (Mechanism)Uncompetitive NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 11673-033_a1e0dc15-5252-43a6-98b0-6200cf5f2adbSPL ID a1e0dc15-5252-43a6-98b0-6200cf5f2adb
Pharmacologic class: Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N411673003305 followed by a unit qualifier and the quantity

Package 11673-0033-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 11673-033

What is NDC 11673-033?: 11673-033 is the product NDC for Dextromethorphan Polistirex, Dextromethorphan 30 mg/5mL suspension, extended release, listed with the FDA by Target Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dextromethorphan Polistirex.
What is the active ingredient?: Dextromethorphan.
Who is the labeler?: Target Corporation, NDC labeler code 11673. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dextromethorphan Polistirex?: 4 other product NDCs are listed under this name. See all Dextromethorphan Polistirex NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dextromethorphan Polistirex NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-617	58602-0617-0558602-0617-06
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-618	58602-0618-0558602-0618-06
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-610	58602-0610-0558602-0610-06
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-611	58602-0611-0558602-0611-06

Other NDCs under ANDA 218417

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218417
Product	Strength	Form · route	Labeler	Product NDC
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-610
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-611
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-617
Dextromethorphan Polistirex	Dextromethorphan 30 mg/5mL	Suspension, Extended releaseOral	Aurohealth LLC	58602-618